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Abstract Mammalian skeletal muscles exhibit age-
related adaptive and pathological remodeling. Several
muscles in particular undergo progressive atrophy and
degeneration beyond median lifespan. To better
understand myocellular responses to aging, we used
semi-quantitative global metabolomic profiling to
characterize trends in metabolic changes between
15-month-old adult and 32-month-old aged Fischer
344 9 Brown Norway (FBN) male rats. The FBN rat
gastrocnemius muscle exhibits age-dependent atro-
phy, whereas the soleus muscle, up until 32 months,
exhibits markedly fewer signs of atrophy. Both
gastrocnemius and soleus muscles were analyzed, as
well as plasma and urine. Compared to adult gastroc-
nemius, aged gastrocnemius showed evidence of
reduced glycolytic metabolism, including accumula-
tion of glycolytic, glycogenolytic, and pentose phos-
phate pathway intermediates. Pyruvate was elevated
with age, yet levels of citrate and nicotinamide
adenine dinucleotide were reduced, consistent with
mitochondrial abnormalities. Indicative of muscle
atrophy, 3-methylhistidine and free amino acids were
elevated in aged gastrocnemius. The monounsaturated
fatty acids oleate, cis-vaccenate, and palmitoleate also
increased in aged gastrocnemius, suggesting altered
lipid metabolism. Compared to gastrocnemius, aged
soleus exhibited far fewer changes in carbohydrate
metabolism, but did show reductions in several
glycolytic intermediates, fumarate, malate, and flavin
adenine dinucleotide. Plasma biochemicals showing
the largest age-related increases included glycocho-
late, heme, 1,5-anhydroglucitol, 1-palmitoleoyl-gly-
cerophosphocholine, palmitoleate, and creatine. These
changes suggest reduced insulin sensitivity in aged
FBN rats. Altogether, these data highlight skeletal
muscle group-specific perturbations of glucose and
lipid metabolism consistent with mitochondrial dys-
function in aged FBN rats.
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Sarcopenia describes the age-related decline in both
lean body mass and skeletal muscle function. Skeletal
muscle weakness in elderly subjects contributes to
both reduced ability to perform usual activities of daily
living and increased susceptibility to slip- and trip-
induced falls (Janssen 2011; Landi et al. 2012).
Resultant lack of independence and rehabilitation
from falls represent significant aging-associated health
economic burdens. As diagnostic criteria for sarcope-
nia continue to be evaluated, it will also be important
to determine the molecular mechanisms that set
sarcopenic muscle apart from otherwise healthy
muscle in elderly subjects. Arriving at a precise
causative model for sarcopenia has been complicated
by its multifactorial etiology. Skeletal muscle function
is dependent on neurological, neuromuscular, vascu-
lar, endocrine, and inflammatory systems which also
decline with age. A second obstacle is predicting how
environmental stimuli contribute to sarcopenia (e.g.,
acute muscle injury, surgery, reduced physical activ-
ity, nutritional status, mood). Perhaps most funda-
mental is our lack of understanding of specifically how
myofibers adapt to the complex sequelae of aging.
Sarcopenia has historically been considered a
disease of the terminally differentiated skeletal myo-
fiber. In particular, glycolytic and oxidative ‘fast-
twitch’ myosin heavy chain (MHC) type II-expressing
myofibers preferentially atrophy and degenerate with
age, compared to the exclusively oxidative, ‘slow-
twitch’ MHC type I-expressing myofibers (Larsson
et al. 1979; Joseph et al. 2012; Nilwik et al. 2013).
Whole muscle groups are mixtures of fast and slow
myofibers. In rats, the gastrocnemius muscle MHC
protein pool comprises*90 % MHC type II and 10 %
MHC type I, while the soleus muscle comprises
*95 % MHC type I and 5 % MHC type II (Staron
et al. 1999; Hepple et al. 2004; Russ et al. 2011). It is
intriguing that co-expression of MHC type II may
contribute significantly to slow myofiber and soleus
atrophy in late old age (Snow et al. 2005; Purves-
Smith et al. 2012). Muscle wasting may be further
enhanced by a reduction in both the number and
activity of regenerative satellite cells (Verdijk et al.
2012) and structural alterations of neuromuscular
junctions (Li et al. 2011). The net physiological effect
of aging on skeletal muscle is loss of strength and
contractile function. Muscle contraction is dependent
on the production of adenosine triphosphate (ATP)
from one of three energetic reactions – anaerobic
glycolysis, mitochondrial oxidative phosphorylation,
and hydrolysis of creatine phosphate. Myosin ATPas-
es use ATP to drive myosin-actin cross-bridge cycling
and muscle contraction. With age, the type II myofiber
exhibits diminished oxidative capacity and ATP
content (Proctor et al. 1995; Drew et al. 2003). Age-
related metabolic dysfunction is further evidenced by
decreased mitochondrial autophagy and increased
mitochondrial oxidative stress, leading to mitochon-
drial loss and myofiber apoptosis (Hagen et al. 2004;
Chabi et al. 2008; Wohlgemuth et al. 2010). In both
humans and rats, aged skeletal muscle tissue may
adapt to type II myofiber loss through type I or mixed
type I/II myofiber regeneration (Weber et al. 2012;
Larsson et al. 1978). This shift toward type I myofiber
repopulation generates an increasingly oxidative, and
thus less energetically costly, metabolic profile in
elderly subjects (Lanza et al. 2005; Hepple et al.
2004). These observations are consistent with a study
showing that oxygen consumption and markers of
mitochondrial oxidative capacity and biogenesis are
increased in sedentary ‘high-functioning’ elderly
subjects, yet decreased in sedentary ‘low-functioning’
elderly subjects (Joseph et al. 2012).
We sought to better understand muscle’s metabolic
response to aging by comprehensive metabolomic
profiling of gastrocnemius and soleus muscles from
15-month-old adult and 32-month-old aged Fischer
344 9 Brown Norway (FBN) male rats. Age-related
loss of skeletal muscle mass has been characterized in
several rat inbred lines, and in particular the type II
fiber-predominant gastrocnemius (Drew et al. 2003).
The FBN rat strain in particular shows not only age-
related changes in muscle weight and body composi-
tion comparable to humans, but also decreases in
functional contractile strength (Rice et al. 2005;
Hepple et al. 2004; Russ et al. 2013). We chose to
compare muscles from 15-month-old adult and
32-month-old aged FBN rats to identify primary
markers of sarcopenia. At 15 months, FBN rats show
mild signs of muscle atrophy while severe sarcopenic
pathology, including extensive fibrosis and muscle
degeneration, appears beyond 32 months of age
(Lushaj et al. 2008). We surveyed several skeletal
muscle groups from FBN rats to guide choice of an
atrophy-prone muscle, gastrocnemius, and a less
atrophy-prone comparator, soleus, for metabolomic
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study. Described herein are metabolomic data from
gastrocnemius, soleus, plasma, and urine of adult and
aged FBN male rats. We also present a novel statistical
workflow by which to differentially analyze ‘semi-
quantitative’ versus ‘qualitative’ biochemicals within
metabolomic datasets where data are ‘missing’ (i.e., a
biochemical is not detected) preferentially from one
experiment group. Altogether, these data highlight
skeletal muscle group-specific metabolic dysfunction
and adaptation in aged skeletal muscle.
Methods
Experimental animals
All experimental procedures were approved by the
Institutional Animal Care & Use Committees at both
The Ohio State University (Columbus, OH) and
Abbott Laboratories (Chicago, IL). For the muscle
morphometric survey, 6- and 32-month-old FBN F1
hybrid male rats were purchased from Harlan (Indi-
anapolis, IN). Western blot and RT-PCR were per-
formed on muscle from these mice, as previously
described (Acharyya et al. 2005). Morphometric and
molecular methods are also detailed in Online
Resource 1. For metabolomic analyses, a separate
cohort of FBN rats was used. Male 15- and 32-month-
old FBN rats were purchased from Harlan. Upon
arrival at The Ohio State University vivarium, rats
were housed individually and provided water and food
(Harlan 8640 Teklad Diet) ad libitum. Rats were
housed for 12 days before being fasted for 16 h
overnight prior to tissue collection. Blood and urine
were collected with needle and syringe, and muscles
were removed and trimmed of excess fat and connec-
tive tissue. Muscles were wrapped in aluminum foil,
frozen in liquid nitrogen, and stored at -80 C.
Global metabolomics
Eight samples per aged and adult experimental groups
were included in the metabolomic analysis of gastroc-
nemius, soleus, and plasma. Five and six urine
specimens were analyzed from adult and aged rats,
respectively. Metabolomic profiling was performed by
Metabolon (Durham, NC, USA), and detailed methods
are provided in Online Resource 1.
Bioinformatics and statistics
Semi-quantitative analysis
Biochemicals had to meet a within-group 70 % fill
threshold for semi-quantitative reporting of relative
fold of change values and statistical analyses by
methods otherwise routinely used for global ‘-omic’
profiling. Thus, if biochemicals were detected in at
least 70 % of each group within a tissue of interest
(e.g., at least 6 of the 8 soleus samples), the missing
data were imputed with the lowest detectable value
(1 9 MIN) specific to the type of specimen, and a
relative ratio was reported. For fold of change
analysis, the values were scaled to the median
intensity for that biochemical: (1) across the two age
groups and across both muscle types, or (2) across the
two age groups and within each of the plasma and
urine datasets. The data were log-transformed for
Welch’s two sample t test to compare data obtained
from 15- and 32-month-old samples. Heat maps show
fold of change values between 32-month-old aged and
15-month-old adult groups. Colored boxes represent
statistically significant differences (P B 0.05). Red
signifies increased levels in aged muscle. Green
signifies decreased levels in aged muscle. For plasma
and urine candidate biomarker analysis, false discov-
ery rate was estimated by Q values. Comparisons
between age groups were taken as significant when
P B 0.05, and Q B 0.10.
Qualitative analysis
For the minority of biochemicals that did not meet the
semi-quantitative reporting threshold, a separate sta-
tistical analysis was applied as a requirement for
qualitative reporting (e.g., reporting of detection
percentage within age groups and display of boxplots).
We considered 3 or more missing values from either
group (representing 37.5 % or more of the available
data of that group within muscle or plasma datasets) as
subject to too much influence of an imputation
assignment. In this case, a rule was applied: if all
available values of one group were entirely above all
available values of another group, and if there were at
least one observation in one group and at least 6
observations in the second group, then this biochem-
ical met the qualitative reporting requirement. The
probability of ‘all of one group’ greater than ‘all of
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another group’ is \0.10 for all of the eligible
combinations of non-missing numbers with these
exceptions. If one group has only one non-missing
value, or the groups are a combination of (4, 2) or (3,
2), the probability is[0.10. This analysis is shown in
Online Resource 2. Note that this approach does not
use the knowledge that a missing value is assumed to
be too low to be measured and therefore lower than the
values that are present.
Results
Muscle morphometry and markers of protein
balance
To help determine choice of tissue for metabolomic
studies, we carried out a morphometric survey of
skeletal muscles from 6- and 32-month-old FBN rats
(Online Resource 3). Between 6 and 32 months,
average gastrocnemius wet weight decreased by
21.0 % (1.95 vs. 1.54 g), normalized weight decreased
by 32.7 % (5.48 vs. 3.69 mg/g body weight), and
myofiber cross-sectional area (CSA) decreased by
44.9 % (1,493 vs. 822 lM2). Soleus wet weight
increased 12.1 % (141 vs. 158 mg) and myofiber
CSA trended 12.4 % upward (780 vs. 877 lM2,
P = 0.07). Plantaris showed no significant morpho-
metric changes, and tibialis anterior showed a signif-
icant change only in normalized wet weight (1.91 vs.
1.55 mg/g body weight) between 6 and 32 months. It
is noted, however, that differences between 6 and
32 months are not continuous, linear changes since
body weight and some muscle weights increase
through late middle age (Lushaj et al. 2008).
Western blot analysis of gastrocnemius lysates
showed an age-related increase in the baseline, non-
fasted levels of several markers of protein synthesis
(i.e., activated insulin receptor, mTOR, and P70S6K1)
(Online Resource 4). The highest molecular weight
4E-BP1 band also suggests increased protein synthesis
with age through increased phosphorylation and
inactivation of the translational repressor protein 4E-
BP1 (Online Resource 4). No change in phospho-Akt1
expression was observed. Western blot also showed an
increase in the activated form of NF-jB (phospho-
p65), an upstream activator of proteasome-dependent
protein degradation (Online Resource 4). RT-PCR
showed increased expression of the protein
degradation markers MuRF1 (muscle RING-finger
protein-1 or TRIM63) and MAFbx (muscle atrophy
F-box protein or atrogin-1 or FBXO32) (Bodine et al.
2001; Gomes et al. 2001) in aged gastrocnemius
(Online Resource 4). These data confirm that the aged
rat gastrocnemius serves as an accurate morphometric
and molecular model of human sarcopenic muscle.
Soleus was also chosen for metabolomic profiling to
extend the analysis to an oxidative, type I fiber-
predominant muscle group which appears less prone to
atrophy in 32-month-old aged FBN rats.
Global metabolic profile of skeletal muscle,
plasma and urine
In total, we analyzed the global metabolic profile of
gastrocnemius, soleus, and plasma from 15-month-old
adult and 32-month-old aged rats (n = 8 per group).
Five adult and six aged urine specimens were also
analyzed. We detected 337 biochemicals in gastroc-
nemius, 327 in soleus, 357 in plasma and 461 in urine.
Of these biochemicals, 220 biochemicals in gastroc-
nemius, 216 in soleus, 239 in plasma and 208 in urine
matched known chemical structures in Metabolon’s
chemical reference library. Of these known biochem-
icals, 190 biochemicals in gastrocnemius, 185 in
soleus, 222 in plasma and 194 in urine met the
reporting threshold for ‘semi-quantitative’ analysis
(i.e., the biochemical was detected in at least 70 % of
samples within each experimental group), and their
fold of change values between 32- and 15-month-old
samples are presented in Online Resources 5–7.
Approximately 45 % of the biochemicals in gastroc-
nemius and soleus and 20 % of the biochemicals in
plasma and urine showed significant age-related
differences (Fig. 1a). The use of imputation methods
had little effect on the muscle metabolomic signatures
(Fig. 1a; Online Resource 8).
A separate min/max analysis for statistical signif-
icance was applied to ‘qualitative’ biochemicals for
which[30 % of samples showed no detectable value
within either age group (Methods; Online Resource 2).
For example, despite only 3 detected values in one
experimental group, xylulose does achieve statistical
significance by this min/max method because all 8
observations in aged gastrocnemius were higher than
the 3 observations in adult gastrocnemius (Online
Resource 2). Altogether, the conservative semi-quan-
titative reporting threshold and min/max analysis for
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qualitative biochemicals were employed to limit
imputation bias and focus interpretation on patterns
from biochemicals within a detectable range. How-
ever, we cannot rule out that biochemicals below
detection limits as well as those that do not meet the
strict min/max test are relevant to aging, especially
those that align within biological pathways implicated
by semi-quantitative differences.
Principal component analysis (PCA) was used to
provide a broad picture of how well aging explains
differences in the muscle datasets. PCA analysis of the
semi-quantitative metabolomic profiles separated age
groups in both gastrocnemius and soleus (Fig. 1b).
The first, second, and third components (i.e., 3
separate weighted sums of the original biochemicals)
explain 36.6, 14.1, and 9.5 % of the variability of the
biochemicals. Altogether, the first 3 components
explain *60.1 % of the variability of the original
biochemicals. The list of most differentially abundant
biochemicals with age (P \ 0.05) shows very differ-
ent profiles for gastrocnemius and soleus (Table 1).
For example, 7 of the top 9 biochemicals more
abundant at 32 months in gastrocnemius are related to
carbohydrate metabolism. Comparing 15- and
32-month-old soleus, 2 TCA intermediates (i.e.,
fumarate and malate) are decreased with age along
with several glycerophospholipids (GPLs) and acyl-
carnitines (Table 1; Online Resource 5). Of the 86 and
75 age-dependent biochemicals identified in gastroc-
nemius and soleus, respectively, 37 were shared and
just 25 of these changed in the same direction (Online
Resource 9), consistent with differential effects of
aging on gastrocnemius and soleus.
Glucose metabolism in skeletal muscle
One of the most striking differences with age between
muscle groups resided in levels of biochemical
markers of glucose metabolism. The levels of several
glycolytic intermediates increased to statistically
significant levels in 32-month-old aged gastrocnemius
(Fig. 2). For example, glucose is 19 % increased and
3-phosphoglycerate is greater than five-fold abundant
in aged gastrocnemius (Fig. 2a). Though not meeting
the semi-quantitative reporting threshold, both the (1)
isobar of fructose-1,6-bisphosphate (FBP) and glu-
cose-1,6-diphosphate and (2) phosphoenolpyruvate
(PEP) are each detected in all 8 aged muscles but only
detected in 3 adult muscles, both passing the min/max
test for a statistically significant increase with aging
(Fig. 2). Concomitant with the change in glycolytic
intermediates during the aging process, there was a
91 % relative decrease in nicotinamide adenine dinu-
cleotide (NAD) levels in aged gastrocnemius (Fig. 2).
With respect to the TCA cycle, NAD depletion was
also associated with a 44 % relative increase in
pyruvate, yet a decrease in citrate (53 %) and succi-
nylcarnitine (37 %), a surrogate marker of succinyl-
CoA levels. Glucose fates alternative to glycolysis
also showed changes with age. Sorbitol increased
significantly with age (58 %) in gastrocnemius. Sev-
eral pentose phosphate pathway intermediates (i.e.,
ribose, ribulose, and the sum of ribulose-5-phosphate
and xylulose-5-phosphate) are also all increased
greater than two-fold in aged gastrocnemius. While
not meeting the semi-quantitative reporting threshold,
xylulose did pass the min/max test for an increase with
aging (Fig. 2b). The glycogen intermediates maltotet-
raose (5.65-fold), maltotriose (7.06-fold), and maltose
(4.43-fold) also increased with age (Fig. 2a).
aged vs. adult # biochemicals
imputation-1xMIN no imputation
gastroc >RT & P<0.05 (total) 86 (190) 88 (190)(↑↓) 67 19 69 19
soleus >RT & P<0.05 (total) 75 (185) 74 (185)(↑↓) 15 60 15 59
plasma >RT & P<0.05 (total) 38 (222) n.p.(↑↓) 17 21
urine >RT & P<0.05 (total) 33 (194) n.p.(↑↓) 21 12
A
B
Fig. 1 Overview of results from the metabolomic study.
a Numbers of identified biochemicals are shown. RT 70 %
filled value reporting threshold for semi-quantitative analysis
(Methods), P P value determined by Welch’s t test of groups
with or without imputation. b Principal components analysis of
the muscle metabolomic matrices. np not performed
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Moreover, maltopentaose was detected in all 8 aged
gastrocnemii but only 3 adult samples, however this
comparison was not statistically significant (Fig. 2b).
Several biochemicals show greater variability in the
aged gastrocnemius, as represented by the boxplots for
xylulose and maltopentaose (Fig. 2b).
On the other hand, the levels of several glycolytic
intermediates [e.g., glucose, glucose-6-phosphate
(G6P), and fructose-6-phosphate] decreased in aged
versus adult soleus. Also opposite to gastrocnemius,
soleus showed decreased levels of several pentose
phosphate pathway intermediates (Fig. 2). Several
TCA cycle intermediates were significantly reduced in
aged soleus (e.g., fumarate, 44 %; malate, 55 %;
succinylcarnitine, 53 %), and flavine adenine dinu-
cleotide (FAD) was decreased 39 % compared to adult
soleus.
Fatty acid metabolism in skeletal muscle
Compared to adult gastrocnemius, aged gastrocne-
mius showed increased levels of glycerol (23 %),
glycerol-3-phosphate (4.73-fold), and several mono-
unsaturated free fatty acids (palmitoleate, 69 %;
oleate, 2.11-fold; cis-vaccenate, 2.35-fold) (Fig. 3).
3-Hydroxybutyrate trended upward with age (46 %,
P = 0.054). Aged gastrocnemius also showed
increased choline (73 %) and glycerophosphocholine
(76 %). Opposite to gastrocnemius, the soleus showed
an age-related decrease in many fatty acids (e.g.,
margarate, 41 %; stearate, 26 %; linoleate, 14 %;
linolenate, 23 %; and dihomo-linolenate, 31 %)
(Fig. 3). Several GPLs were also decreased in aged
soleus (Table 1; Online Resource 5). Both muscle
groups showed reductions in carnitine (gastrocnemius,
23 %; soleus, 27 %) and low molecular weight
acylcarnitines (long chain acylcarnitines were not
measured) (Fig. 3).
Amino acid metabolism in skeletal muscle
We detected 20 proteinogenic amino acids in muscle,
and 16 increased significantly with age in gastrocne-
mius, and 9 increased in soleus with age (Fig. 4a). The
post-translationally modified amino acids 3-methyl-
histidine and N6-trimethyl-lysine increased 43 % and
2.38-fold, respectively, in gastrocnemius with age
(Fig. 4b). These amino acids have previously been
Table 1 Metabolomic survey of most differentially abundant muscle biochemicals (32 vs. 15 months)
Gastrocnemius (n = 8 per group)                                                           Fold of Soleus (n = 8 per group)                                                                                  Fold of
change change
maltotriose  7.06 urocanate  2.69
maltotetraose  5.65 spermidine  1.91
3-phosphoglycerate  5.58 butyrylcarnitine  1.75
glycerol 3-phosphate (G3P)  4.73 fumarate  0.56
maltose  4.43 propionylcarnitine  0.56
ribulose  2.88 1-stearoylglycerophosphoinositol  0.54
cytidine  2.67 pantothenate  0.54
ribose 5-phosphate  2.63 lactate  0.52
ribulose 5-phosphate + xylulose 5-phosphate  2.61 caproate (6:0)  0.52
uracil  2.54 isobutyrylcarnitine  0.51
glycerate  2.53 urea  0.50
N-6-trimethyllysine  2.38 2-linoleoylglycerophosphocholine  0.49
cis-vaccenate (18:1n7)  2.35 hydroxyisovaleroyl carnitine  0.48
urocanate  2.28 succinylcarnitine  0.47
arginine  2.27 3-dehydrocarnitine  0.47
mannose  2.18 1-arachidonoylglycerophosphoethanolamine  0.46
oleate (18:1n9)  2.11 malate  0.45
cysteine-glutathione disulfide 2.08 aspartate  0.44
1,5-anhydroglucitol (1,5-AG)  2.07 adenosine 5'-diphosphate (ADP)  0.44
ribose  2.04 uridine  0.38
citrate  0.47 1-stearoylglycerophosphoethanolamine  0.33
leucylleucine  0.38 2-arachidonoylglycerophosphoethanolamine  0.32
cytidine 5'-monophosphate (5'-CMP)  0.32 guanosine  0.32
alanyltyrosine  0.27 1-palmitoylglycerophosphocholine  0.27
isoleucylleucine  0.26 1-stearoylglycerophosphocholine  0.24
pyroglutamine  0.13 2-docosahexaenoylglycerophosphoethanolamine   0.24
nicotinamide adenine dinucleotide (NAD)  0.09 pyroglutamine  0.10
Heat map shows statistically significant (P < 0.05) fold of change values between 32-month-old aged and 15-month-old adult groups. Red signifies increased
levels in aged muscle. Green signifies decreased levels in aged muscle
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Gastroc Soleus
Pathway Biochemical 32 month vs. 15 month
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characterized as markers of muscle damage (Lukaski
et al. 1981). In addition, the dipeptides carnosine,
carnitine, and anserine were all decreased with age in
both muscle groups (Online Resource 5).
Plasma and urine biochemicals associated
with aging
A statistical method was employed to elucidate
candidate plasma and urine biomarkers of aging.
Biochemicals detected in plasma or urine with P value
B0.05, Q value B0.10, and percent change [20 %
between 15- and 32-month-old rats, were then ranked
by fold of change (Table 2). These biochemicals serve
as candidate biomarkers of aging in the FBN rat
model. Of the 25 plasma biomarkers, 8 biochemicals
also showed a significant change between aged and
adult gastrocnemius, and with the exception of
creatine, these changes were in the same direction.
Of these 8 biochemicals, linear regression analysis of
the aged samples alone showed that the levels of 3
biochemicals (i.e., 1,5-anhydroglucitol, 20-deoxycyti-
dine, and pyroglutamine) in plasma were significantly
correlated with levels in gastrocnemius (R2 [ 0.70
and P \ 0.05, Table 2). In particular, 1,5-anhydrog-
lucitol (1-5-AG) showed the strongest correlation
(R2 = 0.77; P = 0.004) between plasma and gastroc-
nemius. Comparing aged and adult soleus, 1,5-AG
levels were not significantly different. Of the 14 urine
biomarkers, 4 biochemicals (i.e., C-glycosyltrypto-
phan, hypotaurine, 3-methylhistidine, and 3-dehydro-
carnitine) also showed a significant change with age in
gastrocnemius. 3-methylhistidine (3-MeH) was
increased 45 % in the urine from aged rats. As
discussed prior, 3-MeH is a ‘dead-end’ metabolite
that has been used clinically for decades as a urinary
marker of various muscle catabolic conditions (Luka-
ski et al. 1981). 3-MeH levels are increased in aged
gastrocnemius, but not different between aged and
adult soleus (Table 2).
Integrative metabolomics–skeletal muscle aging
in rat versus mouse models
In an effort to test for species translatability of these
metabolomic data, we searched for published reports
that also described metabolomic profiles of skeletal
muscle aging. In particular, we searched for datasets
that both investigated a sarcopenic muscle and also
performed the analysis using Metabolon’s whole-
metabolome profiling platform. To the best of our
knowledge, the one published study that met these
criteria described metabolomic differences in quadri-
ceps muscles from 6- and 24-month-old C57BL/6J
male mice (Houtkooper et al. 2011). Since biochem-
ical intensity values were not reported, we applied the
Welch’s t test to the reported fold of change values
reported in the data supplement. In this mouse study,
173 known biochemicals were reported, with 52
showing significant differences. These data were
compared to the metabolomic data described in this
study of 15- and 32-month-old FBN rat gastrocnemius
muscles. Across both studies, a total of 15 differen-
tially abundant biochemicals representing several
different metabolic pathways were reported in com-
mon (Fig. 5).
Discussion
Sarcopenia describes the age-related loss of lean body
mass and skeletal muscle strength. The multi-factorial
etiology of sarcopenia has challenged attempts to both
establish a clinical definition and understand causative
molecular mechanisms. To better understand the
effects of aging on skeletal muscle, we generated
comprehensive metabolomic profiles from the gas-
trocnemius, soleus, plasma, and urine of 15-month-old
adult and 32-month-old aged FBN male rats. Rat
gastrocnemius muscle is a well-validated model of
human sarcopenic muscle, showing age-related reduc-
tions in both mass and strength (Rice et al. 2005).
Fig. 2 The fates of glucose are shown in the pathway through
sorbitol, glycogen, the pentose phosphate pathway, glycolysis
and the TCA cycle. a Heat map shows fold of change values
between 32-month-old aged and 15-month-old adult groups
within gastrocnemius and soleus datasets. Colored boxes
represent statistically significant differences (P B 0.05). Red
signifies increased levels in aged muscle. Green signifies
decreased levels in aged muscle. Where the semi-quantitative
reporting threshold (RT) was not met for a biochemical (i.e., one
group contained[2 samples with a missing value), the amount
of samples showing a detectable value at 32-months (X) and
15-months (Y) are shown on the left and right sides within the
parenthetical (X|Y). In this case, colored background denotes
statistical significance in a min/max value test (Methods; Online
Resource 2). b Boxplots are shown for key glucose metabolites
and NAD in gastrocnemius. Whiskers represent max and min
values, vertical edges of box represent upper and lower quartiles,
? mean, line median, unfilled circle outlier, ns not significant,
RT semi-quantitative reporting threshold
b
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Relative to adult gastrocnemius, aged gastrocnemius
showed evidence of altered glucose metabolism,
including accumulation of glycolytic, glycogenolytic,
and pentose phosphate pathway intermediates. In
contrast, aged soleus showed reductions in glycolytic
intermediates, and overall, fewer age-related increases
in biochemicals compared to gastrocnemius.
Aged gastrocnemius showed a metabolomic signa-
ture consistent with mitochondrial dysfunction. In
particular, several tricarboxylic acid (TCA) cycle
Gastroc Soleus
Biochemical 32 month vs. 15 month



































































Fig. 4 Increased levels of
amino acids and indications
of muscle degradation with
age. a Heat map shows the
statistically significant
(P B 0.05), positive (red)
or negative (green), fold of
change values between
aged and adult muscle.
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line median, unfilled circle
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glycerol 3-phosphate (G3P) 4.73 0.71
glycerophosphorylcholine (GPC) 1.76 0.86
caproate (6:0) 0.91 0.52
palmitoleate (16:1n7) 1.69 1.20
margarate (17:0) 1.09 0.59
stearate (18:0) 1.09 0.74
oleate (18:1n9) 2.11 1.03
cis-vaccenate (18:1n7) 2.35 1.18
linoleate (18:2n6) 1.29 0.86
linolenate (18:3n3 or 6) 1.34 0.77
eicosenoate (20:1n9 or 11) 1.26 0.58























glycerol free fatty acidsG3P
glycolysis
Fig. 3 Lipolysis of fats
results in the production of
glycerol and free fatty acids.
Heat map shows the
statistically significant
(P B 0.05), positive (red) or
negative (green), fold of
change values between aged
and adult muscle
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Table 2 Candidate plasma and urine biomarkers of aging
Plasma biomarker Fold of change
Plasma Gastroc Soleus
Glycocholate 3.18 – –
Heme 2.22 – –
1,5-Anhydroglucitol (1,5-AG) 2.19 2.07 –
1-Palmitoleoylglycerophosphocholine 1.95 – –
Palmitoleate (16:1n7) 1.64 1.69 –
Creatine 1.53 0.94 0.87
3-Methoxytyrosine 1.51 – –
Alpha-hydroxyisovalerate 1.49 – –
10-Heptadecenoate (17:1n7) 1.40 – –
Threonine 1.35 1.19 1.26
Myristoleate (14:1n5) 1.28 – –
Cis-vaccenate (18:1n7) 1.28 2.35 –
20-Deoxycytidine 1.22 1.76 –
Urea 0.79 – 0.50
Creatinine 0.76 – 0.76
Deoxycarnitine 0.72 – –
Pyridoxate 0.66 – –
Proline-hydroxyproline 0.62 – –
Hippurate 0.60 – –
Threonate 0.53 – –
3-Dehydrocarnitine 0.52 0.58 0.47
Aspartate 0.52 – 0.44
Pantothenate 0.52 – 0.54
3-Phenylpropionate 0.50 – –
Pyroglutamine 0.13 0.13 0.10
Urine biomarker Fold of change
Urine Gastroc Soleus
Imidazole lactate 3.44 – –
3-Methyladipate 2.58 – –
Azelate (nonanedioate) 2.00 – –
Riboflavin (vitamin B2) 1.97 – –
Hexanoylglycine 1.68 – –
C-glycosyltryptophan 1.46 1.46 1.27
Pimelate (heptanedioate) 1.46 – –
Hypotaurine 1.45 1.94 –
3-Methylhistidine (3-MeH) 1.42 1.43 –
Erythronate 1.41 – –
N-acetylhistidine 0.70 – –
3-Dehydrocarnitine 0.52 0.58 0.47
Suberate (octanedioate) 0.51 – –
N-acetylleucine 0.45 – –
Biochemicals shown met the requirements P \ 0.05, Q \ 0.10, and[20 % relative change between 32 and 15 months. – denotes biochemical
was not significantly different between age groups, boldface indicates statistically significant correlation (R2 [ 0.70 and P \ 0.05) of plasma
biomarker with gastrocnemius levels within individual aged rats (n = 8)
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intermediates and cofactors were reduced with age.
Citrate, succinylcarnitine (marker for succinyl-CoA),
and NAD were all decreased in aged gastrocnemius,
relative to adult (Fig. 2). NAD is a critical cofactor for
TCA cycling and mitochondrial biogenesis.
Decreased NAD levels and NAD/NADH redox ratio
were also observed in skeletal muscles of aging mice
and monkeys, respectively (Gomes et al. 2013; Pugh
et al. 2013). NAD-dependent pyruvate decarboxyl-
ation to acetyl CoA immediately precedes the TCA
cycle, so it is interesting that pyruvate was increased
with age (Fig. 2). Acetyl CoA supply may thus be
limited under conditions of NAD depletion (NADH
and acetyl CoA were not measured). Citrate synthase
activity may also be reduced, possibly as a negative
feedback response to mitochondrial dysfunction.
Several mitochondrial enzymes including citrate syn-
thase were less abundant in aged FBN rat and human
skeletal muscle (Hagen et al. 2004; Short et al. 2005).
These data suggest that TCA cycling and ATP
production are impaired in aged, atrophying muscle.
Since this study was carried out on overnight fasted
rats, aged gastrocnemius may adapt acutely by shifting
dysfunctional carbohydrate metabolism toward beta-
oxidation of fatty acids. Aged gastrocnemius showed a
metabolomic signature suggestive of increased lipol-
ysis of fatty acids (Fig. 3). The increased levels of free
fatty acids, however, suggest that beta-oxidation was
impaired, possibly due to mitochondrial abnormali-
ties. Metabolomic studies of mouse and human sera
have also suggested incomplete fatty acid oxidation
with age (Toma´s-Loba et al. 2013; Yu et al. 2012).
Alternatively, accumulation of free fatty acids may
arise from increased adipose infiltration, de novo fatty
acid biosynthesis, or lipid droplets (triglycerides were
not measured). In humans, intramyocellular lipid
droplets increase with age and are negatively associ-
ated with muscle strength (Conte et al. 2013).
Increased lipid droplet size is also seen within skeletal
myofibers of aged, yet pre-sarcopenic monkeys (Pugh
et al. 2013). The overabundance of 16 of the 20
measured canonical proteinogenic amino acids in aged
gastrocnemius suggests increased protein catabolism
to free amino acids, possibly as a source of acetyl CoA
for TCA cycling. It has already been shown that the
ubiquitin proteasome pathway is more active in
30-month-old gastrocnemius relative to 4-month-old
rats (Altun et al. 2010), and this pathway may be
hyperactivated with age in the fasting state. Our
molecular data from 6- to 32-month-old rat gastroc-
nemius confirm that protein degradation is increased
with age, but also that protein synthesis is increased
(Online Resource 4), perhaps to counterbalance pro-
tein degradation and presumably leading to a physi-
ological state of dysregulated protein and energy
balance. These data also fit with and may be exacer-
bated by the larger picture of desensitized insulin
signaling through which the activated insulin receptor
continuously cues muscle protein synthesis by inac-
tivating the translation repressor 4E-BP1 (Online
Resource 4).
Glycolysis is severely perturbed in aged gastroc-
nemius, which shows an overabundance of several
downstream glycolytic intermediates (Fig. 2). These
data suggest impaired glycolysis since glycolytic
enzymes are typically efficient and rapidly convert
excess glucose to pyruvate (Milne et al. 2002). In
particular, the chromatographic isobar of glucose-1,6-
diphosphate and FBP is detected in just 3 adult
gastrocnemius samples, but all of the aged samples.
This could be partly explained by decreased activity of
glyceraldehyde-3-phosphate dehydrogenase (GAP-
DH), which catalyzes the NAD-dependent formation
of 1,3-bisphosphoglycerate from glyceraldehyde-3-
phosphate (GA3P), the direct downstream metabolite
of FBP. GAPDH expression and activity have already
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(Present Study)
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Fig. 5 Venn diagram comparing the age-related FBN rat
gastrocnemius metabolome reported in this study to the
C57BL/6J quadriceps metabolome (Houtkooper et al. 2011)
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(Lowe et al. 2000). Reduction of NAD may contribute
to decreased GAPDH activity, GA3P accumulation
and feedback inhibition of FBP catalysis by aldolase.
PEP was also detected in more aged gastrocnemius
samples (Fig. 2). Pyruvate kinase transfers the phos-
phate from PEP to ADP to form ATP and pyruvate.
This reaction is positively regulated by both excess
upstream FBP and its own substrate PEP (Fenton and
Hutchinson 2009). In this study, however, these
positive effectors appeared unable to promote pyru-
vate kinase activity in aged rat gastrocnemius. It is
interesting that several free amino acids, including
phenylalanine which was more abundant in aged
gastrocnemius (Fig. 4), are allosteric inhibitors of
pyruvate kinase (Williams et al. 2006). In such a way,
free amino acids could promote beta-oxidation during
catabolic states accompanied by glycolytic dysfunc-
tion. Pyruvate also accumulated in aged gastrocne-
mius (Fig. 2), suggesting that pyruvate dehydrogenase
expression or activity is compromised. It is interesting
that the age-related decreases in the expression of
pyruvate dehydrogenase and 6-phosphofructo-2-
kinase/FBP phosphatase are correlated with decreased
muscle mass in Sprague–Dawley (SD) rats (Ibebunjo
et al. 2013). It is not clear whether downregulation of
glycolytic enzymes precedes, contributes to, or fol-
lows from mitochondrial dysfunction in aged muscle.
Intracellular glucose has alternate metabolic fates
which appear to be differentially utilized in aged rat
gastrocnemius. Decreased glycolysis permits both the
packaging of glucose into glycogen and conversion to
sorbitol. In this study, glucose metabolism shifted toward
sorbitol and pentose pathways (Fig. 2). There was also
evidence of severe perturbation of glycogen metabolism
with age. Rather than isomerization to fructose, G6P can
be converted to glucose-1-phosphate (G1P) for concata-
merization and branching by a suite of enzymes to create
glycogen. Glycogen was not directly measured, but we
do report overabundance of several malto-oligosaccha-
rides—intermediates of glycogen metabolism—in aged
rat gastrocnemius relative to adult. The question remains
whether elevated malto-oligosaccharides denote
increased glycogen synthesis or degradation. Age-related
increases in glucose, maltose, and malto-oligosaccha-
rides (Fig. 2) were similarly observed in a metabolomic
study of quadriceps muscles from 6- and 24-month-old
C57BL/6J mice (Houtkooper et al. 2011) (Fig. 5).
Perhaps initial de-branching steps of glycogenolysis
are activated in aged, fasted muscle, but phosphorylase
activity is inhibited and unable to catabolize free
oligosaccharides. An age-related decrease in glycogen
phosphorylase activity has been described in the tibialis
muscle of F344 rats (Montori-Grau et al. 2009), and
UDP-glucose phosphorylase-2 expression is positively
correlated with muscle mass in SD rats (Ibebunjo et al.
2013). Defects in the aging lysosomal compartment may
also contribute to incomplete digestion of glycogen.
Consistent with this interpretation, glycogen content
decreases with age in a study of rectus abdominalis
muscles from FBN rats (Gupta et al. 2000). Other reports
do not agree on effects of aging on muscle glycogen
content (Montori-Grau et al. 2009). Nonetheless, our
data strongly suggest that glucose and glycogen handling
are significantly altered in sarcopenic muscle.
NAD depletion in aged gastrocnemius may result
from and further contribute to the glycolytic and
mitochondrial defects previously discussed. NAD is a
critical electron transporter and enzyme cofactor
throughout mitochondrial respiration and oxidative
phosphorylation. NAD also serves as a substrate for
both the sirtuin family of NAD-dependent histone
deacetylases and the DNA repair enzyme, poly(ADP-
ribose) polymerase (PARP). Aging-related, progres-
sive increase in cellular oxidative damage drives
NAD-consuming PARP activity, thus limiting NAD
supply for respiration and longevity-promoting sirtuin
activities (Pillai et al. 2005; Massudi et al. 2012).
PARP may indeed be a large cellular consumer of
NAD since skeletal muscle of PARP1-deficient mice
display increased NAD content, sirtuin expression,
and mitochondrial biogenesis (Bai et al. 2011). In
another study of liver, heart, kidney, and lung tissues
from 3-, 12-, and 24-month-old Wistar rats, oxidative
damage and PARP activity progressively increase
with age, while antioxidant capacity, NAD content,
and sirtuin-1 activity progressively decline (Braidy e
et al. Braidy et al. 2011). Restoring NAD is thus a
candidate approach for mitigating age-related func-
tional decline in skeletal muscle. Dietary augmenta-
tion of NAD with nicotinamide mononucleotide
increased ATP levels and promoted an oxidative
profile in gastrocnemius of aged mice (Gomes et al.
2013). Moreover, nicotinamide riboside supplemen-
tation in mice fed a high-fat diet increased NAD
content in several tissues including skeletal muscle,
with evidence for increased mitochondrial abundance,
activation of sirtuin target genes, and improved
treadmill running endurance (Canto et al. 2012).
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Whereas gastrocnemius begins to atrophy just
beyond middle age in FBN rats, the soleus does not
atrophy until much older age (Purves-Smith et al.
2012), and may partly explain why soleus shows a
very different metabolomic signature of aging
between 15 and 32 months (Table 1; Online Resource
5). Nonetheless, sub-optimal bioenergetics was indi-
cated. Fumarate and malate are decreased in aged
soleus relative to adult soleus, and the decrease in the
cofactor FAD is predicted to compromise succinate
dehydrogenase activity. Aged soleus showed
decreased levels of glycolytic and pentose phosphate
pathways intermediates, suggesting that glycolysis
and salvage pathways are adaptively upregulated to
generate energy in the fasted state. In parallel, free
fatty acids and acylcarnitines are also decreased in
aged soleus. These data suggest that aged soleus
myofibers do contain functional mitochondria, and
that the supply or storage of carbohydrates and lipid
substrates may be the limiting energetic factor.
Several age-related metabolomic changes in mus-
cle are specific to the soleus. For example, several
GPLs decrease in aged soleus (Online Resource 5).
GPLs are saturated long-chain glycerophospho-etha-
nolamines and -cholines created by the phospholipase-
mediated hydrolysis of polyunsaturated phospholip-
ids. GPLs are critical structural components of the
plasma membrane and promote positive, or fluidizing,
curvature to membranes (Fuller and Rand 2001).
These data suggest that soleus may adapt to aging by
shifting its plasma and organellar membrane lipidomic
profiles over time, or in the fasted state, by acutely
catabolizing GPLs for energy. It is intriguing that
many GPLs are also lowered in elderly human sera
samples compared to younger subjects (Collino et al.
2013). Blood plasma GPLs and other lipids are also
associated with ‘familial longevity’ in middle-aged
offspring of human nonagenarians (Gonzalez-Cova-
rrubias et al. 2013). However, it is not yet known how
the plasma lipidome correlates with and influences the
muscle lipidome, contractile function, and aging.
Analysis of candidate plasma and urine biomarkers of
aging suggest a physiological state of altered glucose
handling and insulin resistance in aged rats. The age-
related increase of plasma monounsaturated fatty acids,
such as palmitoleate (16:1n7) and cis-vaccenate
(18:1n7), suggest increased lipolysis of triglycerides
and reduced uptake by tissues, consistent with insulin
resistance (Table 2; Online Resource 6). 1,5-
Anhydroglucitol (1,5-AG) is also elevated with aging
in plasma and gastrocnemius (Table 2). Serum 1,5-AG is
inversely correlated with diabetes and 2-h postprandial
glucose levels in humans (Yamanouchi et al. 1987;
Stettler et al. 2008). 1,5-AG is the naturally occurring,
metabolically stable 1-deoxy form of glucose which,
during hyperglycemia, is outcompeted by glucose for
renal tubular reabsorption (Kim and Park 2013). Ele-
vated plasma 1,5-AG in aged, fasted rats may reflect
insulin resistance or dysfunctional renal handling of
glucose. The plasma marker creatine is also increased in
aged rats, likely due to skeletal muscle ‘leak,’ as creatine
is decreased in both aged muscle groups (Table 2).
Reduced plasma tryptophan in aged rats (Online
Resource 6) reflects similar observations in metabolomic
studies of human sera samples (Yu et al. 2012; Collino
et al. 2013). Reduced plasma and muscle levels of free
proline-hydroxyproline (Table 2), a dipeptide constitu-
ent of collagen, may reflect less turnover and increased
deposition and cross-linking of collagen during aging.
Gastrocnemius trans-4-hydroxyproline, another amino
acid modification common to collagen, is also reduced
with age (Table 2). Increased collagen deposition and
cross-linking promotes muscle stiffness and reduces joint
mobility in elderly subjects, and joint mobility is even
more limited in elderly subjects with diabetes (Abate
et al. 2011). In urine and muscle, the age-associated
increase in C-glycosyltryptophan (Table 2) may indi-
rectly reflect increased glycosyltransferase activity
against mature proteins. Alternatively, C-glycosyltrypto-
phan may be an enzyme-independent advanced glyca-
tion product similar to carboxymethyllysine (CML).
CML was associated with slow walking speed in a study
of elderly subjects (Semba et al. 2010) and decreased
grip strength in community-dwelling elderly women
(Dalal et al. 2009).
It is important to note several caveats regarding
interpretation of metabolomic data within this study.
The FBN rats used herein were fasted for 16 h
overnight prior to collection of tissue. Fasting is the
standard method to physiologically normalize basal
metabolism across experimental groups, but overnight
fasting is itself a strong experimental stimulus. In
young SD rats, 16 h overnight fasting caused changes
in up to 50 % of the metabolome in serum, urine, and
liver, compared to age-matched rats given ad libitum
access to food (Robertson et al. 2011). Decreased
serum glucose in fasted rats was also associated with
significant changes in the expression of liver genes
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related to glucose metabolism. Thus, the metabolomic
differences that we report herein may not necessarily
be observed postprandially or throughout ad libitum
feeding. A second critical consideration is that skeletal
muscle is a heterogeneous tissue. Not only are muscle
groups comprised of many cell types, but mature
myofibers themselves exist in several metabolic
varieties with varying enzymatic rates. The rat
gastrocnemius is predominantly comprised of type II
myofibers, whereas the soleus predominantly contains
type I myofibers (Staron et al. 1999). In type II fiber-
predominant muscle groups like the gastrocnemius,
ATP is largely derived from glycogen and glucose,
which are anaerobically processed to pyruvate and
lactate in the cytosol or oxidatively processed through
mitochondria. Type I fiber-predominant muscles like
the soleus contain more mitochondria for almost
exclusive oxidative metabolism. Type I myofibers are
thus better primed for TCA cycling of citrate through
initial reaction with acetyl CoA derived either from
pyruvate or catabolism of fatty acids and proteins.
Thus, metabolic changes in whole muscle groups—
especially aged muscle—reflect a complex a mixture
of cells. While 32-month-old muscles were not tested
for MHC content or fiber type distribution in this
study, 28- to 29-month-old gastrocnemius and
30-month-old soleus samples showed little change in
MHC content compared to younger samples of the
same muscles (Hepple et al. 2004; Snow et al. 2005).
A final caveat is that we do not know the effect of acute
differential cage activity the night before tissue
harvest on muscle metabolomic profiles.
These metabolomic data show that aged, fasted rats
exhibit signs of insulin resistance and compromised
muscle energetics. Reduced NAD content in aged
muscle suggests that ATP is also reduced. While ATP
was not measured in this study, isolated mitochondria
from the gastrocnemius of 26-month-old F344 rats
produce 50 % less ATP than 12-month-old controls
(Drew et al. 2003). In addition, a high-resolution in situ
respirometry study of mouse gastrocnemius, and not
soleus, showed decreased mitochondrial efficiency
with aging (Jacobs et al. 2013). Similar data were
generated in aged FBN rats, however mitochondrial
function did not explain the extent of atrophy between
muscle groups (Picard et al. 2011). Beyond mitochon-
drial function, type II myofibers may be compromised
by their energetic reliance on glucose, whose metab-
olism, indirectly based on our metabolomic data from
gastrocnemius, is clearly dysregulated with age. It
would be interesting to test whether differential
processing of intramyocellular lipid droplets contrib-
utes to myofiber type specific pathologies. Aging-
associated changes specific to type II myofiber atrophy
may also include a differential response to decreased
physical activity or neuromuscular changes that impact
sarcoplasmic reticulum function and excitation–con-
traction coupling. Slow type I myofibers may be less
affected by age-related denervation and insulin resis-
tance. It is intriguing that type I myofiber clustering, a
marker of regeneration, occurs differentially in aged
rats and is associated with greater muscle strength
(Weber et al. 2012). In human elderly subjects, markers
of mitochondrial activity and oxidative capacity are
associated with ‘high functioning’ status (Joseph et al.
2012). Further experimentation is needed to test
causation between altered muscle metabolism and
age-related muscle atrophy.
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